Pfizer announced last week that it has named general counsel and Vice Chairman Jeffrey B. Kindler as chief executive officer to replace Hank McKinnell, who will remain chairman of the board of the world's largest drug company until his retirement in February 2007. Pfizer noted that Kindler has been "responsible for many of the company's major corporate functions." Kindler joined the company in 2002, and previously served as executive vice president, corporate relations and general counsel of McDonald's.
August 01, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Pfizer Inc. said Friday it named general counsel and vice chairman Jeffrey B. Kindler as chief executive officer to replace Hank McKinnell, 63, who will remain chairman of the board of the world’s largest drug company until his retirement in February 2007.
Kindler, 51, also was elected to the drugmaker’s board. He joined New York-headquartered Pfizer in 2002 as senior vice president and general counsel, and became vice chairman in 2005.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
McCarter & English, LLP is seeking litigation attorneys for our Newark, NJ offices. Candidates must have 3-6 years of law firm experien...
McCarter & English, LLP is actively seeking a corporate associate for its office located in Boston, MA. Candidate must have 2 - 5 years ...
McCarter & English, LLP is actively seeking a midlevel insurance coverage associate for its Newark, NJ and/or Philadelphia, PA offices. ...
